Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4424)
All Articles published online
|
Apr 15, 2003 (publication date) through Jul 12, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhao XH, Gu SZ, Liu SX, Pan BR. Expression of estrogen receptor and estrogen receptor messenger RNA in gastric carcinoma tissues. World J Gastroenterol 2003; 9(4): 665-669 [PMID: 12679906 DOI: 10.3748/wjg.v9.i4.665] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v9/i4/665.htm |
| Number | Citing Articles |
| 1 |
Outi Nylander-Koski, Tuula Kiviluoto, Pauli Puolakkainen, Eero Kivilaakso, Harri Mustonen. The Effect of Nitric Oxide, Growth Factors, and Estrogen on Gastric Cell Migration. Journal of Surgical Research 2007; 143(2): 230 doi: 10.1016/j.jss.2006.12.002
|
| 2 |
Jun-Ming Guo, Bing-Xiu Xiao, De-Jian Dai, Qiong Liu, Hong-Hui Ma. Effects of daidzein on estrogen-receptor-positive and negative pancreatic cancer cells <i>in vitro</i>. World Journal of Gastroenterology 2004; 10(6): 860-863 doi: 10.3748/wjg.v10.i6.860
|
| 3 |
Muhammad Saif Ur Rahman, Jiang Cao. Estrogen receptors in gastric cancer: Advances and perspectives. World Journal of Gastroenterology 2016; 22(8): 2475-2482 doi: 10.3748/wjg.v22.i8.2475
|
| 4 |
Richard Shore, Håkan Björne, Yoko Omoto, Anna Siemiatkowska, Jan-Åke Gustafsson, Mats Lindblad, Lena Holm. Sex differences and effects of oestrogen in rat gastric mucosal defence. World Journal of Gastroenterology 2017; 23(3): 426-436 doi: 10.3748/wjg.v23.i3.426
|
| 5 |
Evangelos Chandanos, Jesper Lagergren. Oestrogen and the enigmatic male predominance of gastric cancer. European Journal of Cancer 2008; 44(16): 2397 doi: 10.1016/j.ejca.2008.07.031
|
| 6 |
Masao Izawa, Masashi Inoue, Mitsuhiko Osaki, Hisao Ito, Tasuku Harada, Naoki Terakawa, Masahide Ikeguchi. Cytochrome P450 aromatase gene (CYP19) expression in gastric cancer. Gastric Cancer 2008; 11(2): 103 doi: 10.1007/s10120-008-0463-x
|
| 7 |
Neal S. Goldstein, David S. Bosler. Diagnostic Immunohistochemistry. 2006; : 442 doi: 10.1016/B978-0-443-06652-8.50019-3
|
| 8 |
Hua Ge, Yan Yan, Fei Tian, Di Wu, Yongsheng Huang. Prognostic value of estrogen receptor α and estrogen receptor β in gastric cancer based on a meta-analysis and The Cancer Genome Atlas (TCGA) datasets. International Journal of Surgery 2018; 53: 24 doi: 10.1016/j.ijsu.2018.03.027
|
| 9 |
M. Wang, J.-Y. Pan, G.-R. Song, H.-B. Chen, L.-J. An, S.-X. Qu. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: Correlation with prothymosin alpha and clinicopathological parameters. European Journal of Surgical Oncology (EJSO) 2007; 33(2): 195 doi: 10.1016/j.ejso.2006.09.009
|
| 10 |
Xiaowei Wei, Enke Zhang, Chun Wang, Dongying Gu, Lili Shen, Meilin Wang, Zhi Xu, Weida Gong, Cuiju Tang, Jinglong Gao, Jinfei Chen, Zhengdong Zhang, Alice Y. W. Chang. A MAP3k1 SNP Predicts Survival of Gastric Cancer in a Chinese Population. PLoS ONE 2014; 9(4): e96083 doi: 10.1371/journal.pone.0096083
|
| 11 |
JIANJUN WANG, JIAJIA LI, RENGUI FANG, SHUDUO XIE, LINBO WANG, CHAOYANG XU. Expression of ERα36 in gastric cancer samples and their matched normal tissues. Oncology Letters 2012; 3(1): 172 doi: 10.3892/ol.2011.437
|
| 12 |
C Kameda, M Nakamura, H Tanaka, A Yamasaki, M Kubo, M Tanaka, H Onishi, M Katano. Oestrogen receptor-α contributes to the regulation of the hedgehog signalling pathway in ERα-positive gastric cancer. British Journal of Cancer 2010; 102(4): 738 doi: 10.1038/sj.bjc.6605517
|
| 13 |
Shi Wei, Nasser Said-Al-Naief, Omar Hameed. Estrogen and Progesterone Receptor Expression is not Always Specific for Mammary and Gynecologic Carcinomas. Applied Immunohistochemistry & Molecular Morphology 2009; 17(5): 393 doi: 10.1097/PAI.0b013e31819faa07
|
| 14 |
M. Wesołowska, P. Pawlik, P.P. Jagodziński. The clinicopathologic significance of estrogen receptors in human gastric carcinoma. Biomedicine & Pharmacotherapy 2016; 83: 314 doi: 10.1016/j.biopha.2016.06.048
|
| 15 |
J Shi. Relationship between expressions of estrogen and progesterone receptors and syndrome types of gastric carcinoma. Journal of Chinese Integrative Medicine 2010; 8(7): 629 doi: 10.3736/jcim20100705
|
| 16 |
Narayanan Sathiya Pandi, Muthaiah Manimuthu, Palaniswamy Harunipriya, Manikandan Murugesan, George Virumaandi Asha, Suriliyandi Rajendran. In silico analysis of expression pattern of a Wnt/β-catenin responsive gene ANLN in gastric cancer. Gene 2014; 545(1): 23 doi: 10.1016/j.gene.2014.05.013
|
| 17 |
Chew-Wun Wu, Chin-Wen Chi, Tze-Sing Huang. Elevated level of spindle checkprotein MAD2 correlates with cellular mitotic arrest, but not with aneuploidy and clinicopathological characteristics in gastric cancer. World Journal of Gastroenterology 2004; 10(22): 3240-3244 doi: 10.3748/wjg.v10.i22.3240
|
| 18 |
Tamás Deli, Mónika Orosz, Attila Jakab. Hormone Replacement Therapy in Cancer Survivors – Review of the Literature. Pathology & Oncology Research 2020; 26(1): 63 doi: 10.1007/s12253-018-00569-x
|
| 19 |
Wencheng Kong, Guang Yin, Sixin Zheng, Xinchun Liu, Akao Zhu, Panpan Yu, Jian Zhang, Yuqiang Shan, Rongchao Ying, Huicheng Jin. Long noncoding RNA (lncRNA) HOTAIR: Pathogenic roles and therapeutic opportunities in gastric cancer. Genes & Diseases 2022; 9(5): 1269 doi: 10.1016/j.gendis.2021.07.006
|
| 20 |
M‐L F Van Velthuysen, B G Taal, J J M Van Der Hoeven, J L Peterse. Expression of oestrogen receptor and loss of E‐cadherin are diagnostic for gastric metastasis of breast carcinoma. Histopathology 2005; 46(2): 153 doi: 10.1111/j.1365-2559.2005.02062.x
|
| 21 |
Mats Lindblad, Weimin Ye, Carlos Rubio, Jesper Lagergren. Estrogen and Risk of Gastric Cancer: A Protective Effect in a Nationwide Cohort Study of Patients with Prostate Cancer in Sweden. Cancer Epidemiology, Biomarkers & Prevention 2004; 13(12): 2203 doi: 10.1158/1055-9965.2203.13.12
|
| 22 |
Shu-Qing Shi, Jian-Ting Cai, Jian-Ming Yang. Expression of trefoil factors 1 and 2 in precancerous condition and gastric cancer. World Journal of Gastroenterology 2006; 12(19): 3119-3122 doi: 10.3748/wjg.v12.i19.3119
|
| 23 |
Won Jung Bae, Seokhwi Kim, Ji Mi Ahn, Jae Ho Han, Dakeun Lee. Estrogen‐responsive cancer‐associated fibroblasts promote invasive property of gastric cancer in a paracrine manner via CD147 production. The FASEB Journal 2022; 36(11) doi: 10.1096/fj.202200164RR
|
| 24 |
Joo Hyun Lim, Cheol Min Shin, Kyungdo Han, Juhwan Yoo, Eun Hyo Jin, Yoon Jin Choi, Dong Ho Lee. Nationwide cohort study: cholesterol level is inversely related with the risk of gastric cancer among postmenopausal women. Gastric Cancer 2022; 25(1): 11 doi: 10.1007/s10120-021-01241-1
|
| 25 |
Nicoletta Biglia, Angelo Gadducci, Riccardo Ponzone, Riccardo Roagna, Piero Sismondi. Hormone replacement therapy in cancer survivors. Maturitas 2004; 48(4): 333 doi: 10.1016/j.maturitas.2003.09.031
|
| 26 |
JICHUN ZHOU, RONGYUE TENG, CHAOYANG XU, QINCHUAN WANG, JUFENG GUO, CHENPU XU, ZIDUO LI, SHUDUO XIE, JIANGUO SHEN, LINBO WANG. Overexpression of ERα inhibits proliferation and invasion of MKN28 gastric cancer cells by suppressing β-catenin. Oncology Reports 2013; 30(4): 1622 doi: 10.3892/or.2013.2610
|
| 27 |
S Matsusaka, A H Wu, S Cao, D L Hanna, K Chin, D Yang, W Zhang, Y Ning, S Stintzing, A Sebio, Y Sunakawa, S Stremitzer, S Yamauchi, S Okazaki, M D Berger, A Parekh, Y Miyamoto, N Mizunuma, H-J Lenz. Prognostic impact of FOXF1 polymorphisms in gastric cancer patients. The Pharmacogenomics Journal 2018; 18(2): 262 doi: 10.1038/tpj.2017.9
|
| 28 |
Afang Zhu, Shujia Song, Lijian Pei, Yuguang Huang. Supportive care of female hormones in brain health: what and how?. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1403969
|
| 29 |
Sindhu Sekar, Bid Kumar. Hormone replacement therapy and non-gynaecological cancers. Post Reproductive Health 2024; 30(4): 246 doi: 10.1177/20533691241304028
|
| 30 |
A.M. Hogan, D. Collins, A.W. Baird, D.C. Winter. Estrogen and gastrointestinal malignancy. Molecular and Cellular Endocrinology 2009; 307(1-2): 19 doi: 10.1016/j.mce.2009.03.016
|
| 31 |
R Chakrabarti, D Holloway, D Bruce, J Rymer. The management of menopausal symptoms in women following treatment for cancer at a specialist menopause service. Post Reproductive Health 2021; 27(3): 137 doi: 10.1177/20533691211000548
|
| 32 |
Luísa Glória, Nadine Bossard, Anne-Marie Bouvier, Alexandra Mayer-da-Silva, Jean Faivre, Ana Miranda. Trends in net survival from stomach cancer in six European Latin countries: results from the SUDCAN population-based study. European Journal of Cancer Prevention 2017; 26: S32 doi: 10.1097/CEJ.0000000000000309
|
| 33 |
Li-Qun Xie, Jie-Ping Yu, He-Sheng Luo. Expression of estrogen receptor β in human colorectal cancer. World Journal of Gastroenterology 2004; 10(2): 214-217 doi: 10.3748/wjg.v10.i2.214
|
| 34 |
Yang Li, Yu-Xin Zhong, Quan Xu, Yan-Tao Tian. Protective effects of female reproductive factors on gastric signet-ring cell carcinoma. World Journal of Clinical Cases 2022; 10(16): 5217-5229 doi: 10.12998/wjcc.v10.i16.5217
|